NASDAQ · Biotechnology

PASG (PASG) Stock

$4.49 +0.45% NASDAQ: PASG Healthcare

Valuation

MetricValue
Price$4.49
Market Cap$14.43M
P/E Ratio-0.36
P/B Ratio0.88
P/S Ratio0.00
EPS (TTM)$-14.35
52-Week High$20.00
52-Week Low$3.39
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-242.11%
ROA-74.19%
ROCE-238.89%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.49
Current Ratio2.09

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-186.0M$-138.0M$-100.0M$-70.0M$-43.0M
Net Profit$-185.0M$-136.0M$-102.0M$-65.0M$-46.0M
EPS$-69.51$-50.00$-37.29$-21.44$-14.35
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$355.0M$244.0M$151.0M$102.0M$62.0M
Total Liabilities$36.0M$42.0M$39.0M$41.0M$44.0M
Cash$129.0M$35.0M$22.0M$38.0M$46.0M
Borrowings$0$27.0M$26.0M$25.0M$24.0M

Latest News

Top Premarket Decliners MT Newswires · Jun 25, 2026 Remix to go public in reverse merger with once high-flying Passage Bio BioPharma Dive · Jun 25, 2026 SPRY, PASG, BOXL: Why These Stocks Plunged Double Digits In After-Hours Trading Today Stocktwits · Jun 25, 2026 PASG Stock Slumps 16% After-Hours — What’s Driving The Selloff? Stocktwits · Jun 24, 2026 Passage Bio, Remix Therapeutics Plan All-Stock Merger MT Newswires · Jun 24, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-127.0M$-118.0M$-78.0M$-48.0M$-32.0M
Investing Cash Flow$-71.0M$20.0M$65.0M$55.0M$40.0M
Financing Cash Flow$0$-2.0M$0$0$0
Net Cash Flow$-6.0M$-94.0M$-13.0M$16.0M$9.0M
Free Cash Flow$-153.0M$-123.0M$-78.0M$-48.0M$-32.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-183.74%
Quick Ratio1.73
Interest Coverage—
Return 1Y-17.55%
Return 3Y-75.57%
Return 5Y-98.01%

Ownership

Insiders Held7.72%
Institutions Held60.32%
Institutions Float Held65.37%
Institutional HolderSharesReport Date
Lynx1 Capital Management Lp623,7042026-03-31
Vestal Point Capital, LP305,0002026-03-31
Renaissance Technologies, LLC133,6122026-03-31
Eversept Partners, LP131,5812026-03-31
Vanguard Capital Management LLC113,9642026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALLR $1.39 -0.71% -1.91 $22.12M 0.00%
CASICASI Pharmaceuticals, Inc. $0.15 +3.08% -0.07 $2.33M 0.00%
CING $4.52 -2.59% -1.08 $25.34M 0.00%
CLGN $0.27 -9.04% -0.48 $3.54M 0.00%
ENLV $2.12 -5.36% 0.03 $35.68M 0.00%

About PASG

PASG is led by CEO William Chou, employs 60 people, headquartered in US, publicly traded since 2020.

PASG stock trades at $4.49 with a market capitalization of $14.43M. The stock is valued at a price-to-earnings (P/E) ratio of -0.36, price-to-book of 0.88, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $3.39 and $20.00, and currently trades 77.5% below its 52-week high.

On profitability, PASG generates a return on equity (ROE) of -242.11%, return on capital employed of -238.89%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides